| 1 |
CELGENE CORPORATION v. EMCURE PHARMACEUTICALS LTD. et al |
3:18-cv-11218 |
D.N.J. |
|
|
|
|
| 2 |
Sanofi-Aventis U.S. LLC et al v. Emcure Pharmaceuticals Ltd. et al |
1:16-cv-01330 |
D.Del. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
| 3 |
Sanofi-Aventis U.S. LLC et al v. Emcure Pharmaceuticals Ltd. et al |
1:16-cv-01330 |
D.Del. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
| 4 |
Sanofi-Aventis U.S. LLC et al v. Emcure Pharmaceuticals Ltd. et al |
1:16-cv-01330 |
D.Del. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
| 5 |
Sanofi-Aventis U.S. LLC et al v. Emcure Pharmaceuticals Ltd. et al |
1:16-cv-01330 |
D.Del. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
| 6 |
NOVARTIS PHARMCEUTICALS CORPORATION v. HERITAGE PHARMA HOLDINGS, INC. et al |
2:15-cv-01872 |
D.N.J. |
|
|
|
|
| 7 |
WARNER CHILCOTT COMPANY, LLC et al v. HERITAGE PHARMACEUTICALS INC. |
2:10-cv-01401 |
D.N.J. |
|
|
|
|
| 8 |
WARNER CHILCOTT COMPANY, LLC et al v. HERITAGE PHARMACEUTICALS INC. |
2:10-cv-01401 |
D.N.J. |
|
|
|
|